Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance
October 16 2019 - 5:30AM
Business Wire
CertainT
Platform Complemented by Stable-Isotopic Indicators Offers Brand
Owners Increased Supply Chain Transparency and Product and Process
Authentication
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”, the
“Company”), a leader in polymerase chain reaction (PCR)-based DNA
manufacturing for product authenticity and traceability solutions,
announced today that it has entered into a partnership with
Molecular Isotope Technologies, LLC (“MIT LLC”), a pioneer and
leader in the application of natural-abundance stable-isotopic
analysis provided under the trademarks Nature’s Fingerprint® and
IsoPedigree™. MIT LLC’s technology utilizes stable isotopic
"fingerprints" as a method for verification of product origin and
supply chain processing to support product claims.
For 20 years MIT LLC has provided patented services to the
bio/pharmaceutical industry which have been successfully employed
in various legal matters, supporting pharmaceutical
patent-infringement and fraud lawsuits. These authentication
services are tailored to specific product and supply chain
processes and will be offered by Applied DNA as an additional
component of its CertainT® platform to tag, test and track raw
materials and finished goods. MIT LLC will support and promote the
CertainT platform as a service complementary to its own.
“Through the combined power of our cutting-edge technologies,
Applied DNA offers brand owners “one-stop-shop” access to unique
analytical tools to verify product and process authenticity for
brand assurance and provenance with forensic certainty. This
partnership with MIT LLC enhances Applied DNA’s CertainT
feature-set by offering additional datapoints for deeper product
and supply chain intelligence supported by world-class forensic
laboratory services. The large-scale tagging and authentication of
customer-specific DNA identity at most any supply chain node,
combined with genotyping identification allies perfectly with
stable-isotopic identification of origin and process. We expect our
enhanced portfolio will serve to further our penetration of key
markets such as textiles, adding another level of identity for
organic cotton, among other natural materials,” stated Judy Murrah,
chief information officer of Applied DNA.
Dr. John P. Jasper, chief scientific officer and founder of MIT
LLC, said, “Our partnership with Applied DNA offers great
specificity in forensic authentication to our joint customers,
amplifying product and process claims throughout highly complex
global supply chains. Nearly 40 years of work in this area of
natural-abundance stable-isotope science and service across several
industries has led to a deep knowledge and insight into the
chemistry which has evolved into patented processes for protecting
intellectual-property and product claims.”
Stable-isotopic “fingerprints” within materials provide innate
chemical evidence of their chemical, geographic, and industrial
provenance and major processing-dependent characteristics. They
derive from the natural abundance of various stable isotopes
including carbon, nitrogen, oxygen, sulfur and others that vary in
their isotopic ratios and are present in soil, water and other
organic materials and become integrated with the chemical
composition of a product from raw materials through synthetic
intermediates to finished products. Discrete process steps may
alter isotopic fingerprints, permitting the identification of
deviations in locale or materiel. MIT LLC’s existing and pending
patents variously encompass the use of natural-abundance
stable-isotopic analysis for establishing both product and process
fingerprints.
About Molecular Isotopes Technologies, LLC
Founded in 1999, Molecular Isotope Technologies (MIT LLC) owns
and uses the trademarks Nature’s Fingerprint® and IsoPedigree™. Via
highly precise natural-abundance stable-isotopic analysis, MIT LLC
significantly contributes to the definition of
intellectual-property provenance and to the mitigation of
intellectual-property infringement of various organic (e.g.,
bio/pharmaceutical, agricultural, and other) products and the
synthetic pathways by which they were produced. After having
established the isotopic provenance and process pathways of various
bio/pharmaceutical materials, MIT LLC has provided the isotopic
evidence that has protected more than $2 billion of
bio/pharmaceutical products.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and isolation of circulating tumor
cells and the development of pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements describe Applied DNA’s future plans, projections,
strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are
beyond the control of Applied DNA. Actual results could differ
materially from those projected due to its ability to continue as a
going concern, its history of net losses, limited financial
resources, limited market acceptance, uncertainties relating to its
ability to maintain its NASDAQ listing in light of delisting
notices received and its recent hearing, our ability to penetrate
key markets, and various other factors detailed from time to time
in Applied DNA’s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 18, 2018, as amended, our
subsequent quarterly reports on Form 10-Q filed on February 7,
2019, May 9, 2019 and August 13, 2019, and other reports we file
with the SEC, which are available at www.sec.gov. Applied DNA
undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances
after the date hereof or to reflect the occurrence of unanticipated
events, unless otherwise required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191016005069/en/
Investor: Sanjay M. Hurry, LHA Investor Relations,
212-838-3777, shurry@lhai.com Program: Judy Murrah, Chief
Information Officer, 631-240-8819, judy.murrah@adnas.com
Web: www.adnas.com Twitter: @apdn
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024